JAMA:http://jama.jamanetwork.com/article.aspx?articleid=1791497
(参考:http://kaigyoi.blogspot.jp/2013/12/jnc8.html)
エビデンスに基づかず、医学的に有害で経済的にも有害という主張。
http://www.kevinmd.com/blog/2014/01/call-retract-jnc8-hypertension-guidelines.html
- “The evidence review did not include observational studies, systematic reviews, or meta-analyses, and the panel did not conduct its own meta-analysis based on prespecified inclusion criteria. Thus, information from these types of studies was not incorporated into the evidence statements or recommendations.”
- “Although adverse effects and harms of antihypertensive treatment documented in the randomized controlled trials (RCTs) were considered when the panel made its decisions, the review was not designed to determine whether therapy-associated adverse effects and harms resulted in significant changes in important health outcomes.”
今までは、ガイドライン発表後、従順な解説に終始することが多かった医療系ITメディア
流れが変わってきたのか?
わるいことではないと私は思う。
0 件のコメント:
コメントを投稿